期刊文献+

糖尿病伴冠心病患者血浆游离肉碱水平的相关性研究 被引量:3

Correlative Research of Plasma Free Carnitine Lever in Diabetes Patients Accompanied with Coronary Heart Disease
下载PDF
导出
摘要 目的:研究肉碱在糖尿病、冠心病及糖尿病合并冠心病状态下的变化情况,探讨肉碱与上述疾病的关系,以便为肉碱的临床应用提供理论依据。方法:选择106例观察对象,分为正常对照组、糖尿病组、冠心病组、糖尿病伴冠心病组,通过酶联荧光法检测上述观察对象的血浆游离肉碱浓度。结果:正常对照组、糖尿病组、冠心病组糖尿病伴心脏病组血浆游离肉碱浓度分别为(72.51±9.76)μm o l/L、(59.83±14.56)μm o l/L、(64.13±12.59)μm o l/L、(52.18±11.43)μm o l/L。结论:糖尿病患者、冠心病患者血浆中游离肉碱水平较健康人显著下降;糖尿病伴冠心病患者血浆中游离肉碱水平较单纯糖尿病患者及冠心病患者均显著下降。 Objective:To determine serum free carnitine in diabetes,coronary heart disease (CHD) and diabetes accompanied with CHD patients, and explore the relationships between carnitine and the disease so as to provide theoretic base for the clinical application. Methods: 106 persons were recruited into this study. They were divided into normal group, diabetes group, CHD group and diabetes accompanied with CHD group. We determined the free carnitine concentration in serum by enzymoispectrofluorimetry. Results: Free carnitine level in serum in the normal group, diabetes g:oup, CHD group and diabetes accompanied with CHD group was respectively (72.51±9.76)μmol/L, (59.83±14.56)μmol/L, (64.13±12. 59) μmol/L and (52. 18±11.43) μmol/L. Conclusions:Free carnitine level in serum is significantly lower in both the diabetes and CHD group than in the normal group,and the diabetes accompanied with CHD group's was significantly lower than either diabetes or coronary heart disease group.
出处 《中国误诊学杂志》 CAS 2006年第19期3687-3688,共2页 Chinese Journal of Misdiagnostics
关键词 肉碱/血液 糖尿病/血液 糖尿病/并发症 冠状动脉疾病/并发症 Carnitine/blood Diabetes Mellitus/blood Diabetes Mellitus/complications Coronary disease/complica-tions
  • 相关文献

参考文献6

  • 1梁彦辉,王玉莲.肉碱的临床研究和应用[J].医学综述,2004,10(7):443-445. 被引量:12
  • 2杨瑞锋,李志艳,徐国宾,夏铁安.肉毒碱的生物学特性及其与临床疾病的关系[J].中国实验诊断学,2005,9(2):310-313. 被引量:15
  • 3Calvani M,Reda E,Arrigoni-Martelli E.Regulation by carnitine of myocardial faity acid and carbohgdrate metabolism under normal and pathological conditio ns[J].Basic Res Cardiol,2000,95(2):75-83.
  • 4Yun-Ping Zhou,Per-Olof Berggren,Valdemar Grill.Afatty Acid-Induced Decrease in Pyruvate Dehydrogenase Activity Is an Important Determinant of -Cell Dysfunction in the Obese Diabetic db/db Mouse[J].Diabetes,1996,45(5 ):580- 585.
  • 5Colonna P,Jliceto S.Myocadial infarction and left ventricular remodeling:results of the CEDIM trial. Carnitine Ecocardilgrafia Digitalizzata Infarto Miocardico[J].Am Heart J,2000,139(2 pt 3):s124-s130.
  • 6Bartels GL,Remme WJ,Scholte HR.Acute myocardial ischaemia induces cardiac carnitine release in man[J].European Heart Journal,1997,18(1):84-90.

二级参考文献44

  • 1冯宇,郭长江,韦京豫,章广远,高兰兴.半饥饿状态下高脂喂养对大鼠肉毒碱及脂类代谢的影响[J].中国临床营养杂志,2000,8(2):96-99. 被引量:4
  • 2顾天爵.生物化学[M].北京:人民卫生出版社,1998.136-147.
  • 3Rebouche CJ, Bosch EP, Chenard CA, etal. Utilization of dietary precursors for camitine biosynthesis in human adults[J]. J Nutr, 1989,119(12): 1907.
  • 4Engel AG, Rebouche CJ. C amitine metabolism and inborn errors[J]. J Inherit Metab Dis, 1984,7(suppl 1):38.
  • 5Rebouche CJ, Engel AG. Camitine metabolism and deficiency syndromes[J]. Mayo Clin Proc, 1983,58(8):533.
  • 6Corsi M. Clinical aspects of human carnitine deficiency[M]. New York:Plenum Press, 185.
  • 7Lahjouji K, Mitchell GA, Qureshi IA. Carnitine transport by organic cation transporters and systemic camitine deficiency[J]. Mol Genet Metab,2001,73(4) :287.
  • 8Bieber LL. Camitine[J]. Annu Rev Biochem, 1988,57:261.
  • 9Joaquin Arenas,Juan C Rubio, Miguel A,et al. Biological roles of L-carnitine in perinatal metabolism[J]. Early Hum Der, 1998,53(suppl) :43.
  • 10Jean-Paul Bonnefont, France Demaugre, Carina Prip-Buus, et al. Carnitine Palmitoyltransferase Deficiencies[J]. Mol Gen Metab, 1999,68(4):424.

共引文献23

同被引文献29

  • 1梁彦辉,王玉莲.肉碱的临床研究和应用[J].医学综述,2004,10(7):443-445. 被引量:12
  • 2杨瑞锋,李志艳,徐国宾,夏铁安.肉毒碱的生物学特性及其与临床疾病的关系[J].中国实验诊断学,2005,9(2):310-313. 被引量:15
  • 3陆志范,周全保.赖氨酸的药用功能[J].药学实践杂志,1996,14(4):255-256. 被引量:18
  • 4He-ping CHENG,Sheng WEI,Li-ping WEI,Alexei VERKHRATSKY.Calcium signaling in physiology and pathophysiology[J].Acta Pharmacologica Sinica,2006,27(7):767-772. 被引量:9
  • 5张杰,李涢.关于中医证候物质基础研究路径的思考[J].中国中医基础医学杂志,2007,13(5):394-395. 被引量:41
  • 6Patrizia B,Ivano B,Claudio L,et al.Standard operating procedures for pre-analytical handling of blood and urine for metabolomic srudies and biobanksj Biomol NMR,2011,49(3-4):231-243.
  • 7Mayr M,Chung Y,Mayr U,et al.Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation,oxidative stress,and energy metabolism.Arterioscle Thromb Vase Biol,2005(10),25:2135-2142.
  • 8Brindle J T^Antti H,Holmes E,et al.Rapid and non-invasive di^nosis of the presence and severity of coronaiy heart disease using NMR based metabonomicsJVat Med^002,8(12):1439-1444.
  • 9Bemal-Mizrachi C,Gates A C,Weng S,et al.Vascular respiratory uncoupling increases blood pressure and atherosclerosis.Nature,2005,435(7041):502-506.
  • 10Nicholson J K,Connelly J,Lindon J C,et al.Metabolomics:a platform for studying drug toxicity and gene function.Nat Rev Drug Discov,2002,1(2):153-161.

引证文献3

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部